Skip to main content

Are individuals who were vaccinated as part of a clinical trial considered fully vaccinated?

Individuals who received a full series of an active COVID-19 vaccine are considered fully vaccinated two weeks after completing the series if the vaccine is listed for emergency use by the World Health Organization or if vaccine efficacy has been independently confirmed (e.g., by a data and safety monitoring board).

  • Currently the AstraZeneca COVID-19 vaccine and the Novavax COVID-19 vaccine meet the criteria.
  • Individuals who received a placebo, or are not two weeks out from completing the series are not fully vaccinated.